Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence van Hunsel

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Expert Opinion on Drug Safety|October 14, 2024
Achieving patient engagement in pharmacovigilance: from high-income countries to lower and -middle-income countries with focus on AfricaGeorge Tsey Sabblah, Katja Taxis, Mahama Duwiejua, et al.
Vaccine|August 7, 2025
Adverse drug reactions following SARS-CoV-2 vaccination of 3805 healthcare workers cause substantial sick-leave and are correlated to vaccine regimen, age, sex and serological responseAnna-Karin Lidström, Bo Albinsson, Fredrik Sund, et al.
British Journal of Clinical Pharmacology|May 24, 2023
Menstrual abnormalities after COVID-19 vaccination in the Netherlands: A description of spontaneous and longitudinal patient-reported dataJanneke W Duijster, Mark E Schoep, Theodoor E Nieboer, et al.
Drug Safety|December 11, 2025
GP Consultations for Herpes Zoster After COVID-19 Vaccination: A Self-Controlled Cohort Study Based on Electronic Health Record Data from the NetherlandsRana Jajou, Eugène van Puijenbroek, Jetty Overbeek, et al.
Therapeutic Advances in Drug Safety|January 31, 2024
Medication errors by caregivers in the homes of children discharged from a pediatric department in GhanaGeorge Tsey Sabblah, Florence van Hunsel, Katja Taxis, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Longitudinal Cohort Event Monitoring of MMR and DT-IPV Vaccination at 9 Years of Age in The NetherlandsMonika Raethke, Jeroen Gorter, Rachel Kalf, et al.
Clinical Therapeutics|January 17, 2024
The International Working Group on New Developments in Pharmacovigilance: Advancing Methods and Communication in PharmacovigilanceDawn Cooper, Robert W Platt, Florence van Hunsel, et al.
Pharmacoepidemiology and Drug Safety|February 26, 2011
The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case-control studyFlorence van Hunsel, Attje Talsma, Eugène van Puijenbroek, et al.
Drug Safety|May 20, 2008
Adverse drug reaction reporting by patients in the Netherlands: three years of experienceJoyce de Langen, Florence van Hunsel, Anneke Passier, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 12, 2018
[Neurotropic disease after vaccination against yellow fever]Rozanne E Tijssen, Gisela M Steenvoorden, Marjolein E de Gruijter, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Expert Opinion on Drug Safety|October 14, 2024
Achieving patient engagement in pharmacovigilance: from high-income countries to lower and -middle-income countries with focus on AfricaGeorge Tsey Sabblah, Katja Taxis, Mahama Duwiejua, et al.
Vaccine|August 7, 2025
Adverse drug reactions following SARS-CoV-2 vaccination of 3805 healthcare workers cause substantial sick-leave and are correlated to vaccine regimen, age, sex and serological responseAnna-Karin Lidström, Bo Albinsson, Fredrik Sund, et al.
British Journal of Clinical Pharmacology|May 24, 2023
Menstrual abnormalities after COVID-19 vaccination in the Netherlands: A description of spontaneous and longitudinal patient-reported dataJanneke W Duijster, Mark E Schoep, Theodoor E Nieboer, et al.
Drug Safety|December 11, 2025
GP Consultations for Herpes Zoster After COVID-19 Vaccination: A Self-Controlled Cohort Study Based on Electronic Health Record Data from the NetherlandsRana Jajou, Eugène van Puijenbroek, Jetty Overbeek, et al.
Therapeutic Advances in Drug Safety|January 31, 2024
Medication errors by caregivers in the homes of children discharged from a pediatric department in GhanaGeorge Tsey Sabblah, Florence van Hunsel, Katja Taxis, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Longitudinal Cohort Event Monitoring of MMR and DT-IPV Vaccination at 9 Years of Age in The NetherlandsMonika Raethke, Jeroen Gorter, Rachel Kalf, et al.
Clinical Therapeutics|January 17, 2024
The International Working Group on New Developments in Pharmacovigilance: Advancing Methods and Communication in PharmacovigilanceDawn Cooper, Robert W Platt, Florence van Hunsel, et al.
Pharmacoepidemiology and Drug Safety|February 26, 2011
The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case-control studyFlorence van Hunsel, Attje Talsma, Eugène van Puijenbroek, et al.
Drug Safety|May 20, 2008
Adverse drug reaction reporting by patients in the Netherlands: three years of experienceJoyce de Langen, Florence van Hunsel, Anneke Passier, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 12, 2018
[Neurotropic disease after vaccination against yellow fever]Rozanne E Tijssen, Gisela M Steenvoorden, Marjolein E de Gruijter, et al.
Pageof 10